Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- CheckyesterdayChange DetectedRecruitment is now listed as No longer looking for participants, indicating enrollment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting along with a revision note to reflect documentation improvements.SummaryDifference0.5%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the prior v3.5.4. This reflects a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a metadata-only update to the page. No substantive study content or functionality changes are indicated.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than a change to the study details.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now shows Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.